Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Bleximenib's trials
cAMeLot-1
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Bleximenib
Ongoing
Recruiting
Phase 1
Open NCT04811560 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
cAMeLot-1 · Trial Tracker · ComplyRx
